Efficacy and safety of abobotulinumtoxinA in pediatric lower limb spasticity (PLLS): 2nd interim results from a Phase IV, prospective, observational, multicenter study

Authors

Mark Gormley, Gillette Children's Specialty Healthcare, St. Paul, MN
Edward Dabrowski, Oakland University School of Medicine, Grosse Point, MI
Ann Tilton, LSU Health Sciences Center - New OrleansFollow
Asare Christian, Good Shepherd Rehabilitation Hospital, Allentown, PA
Sarah Helen Evans, Children's Hospital of Philadelphia, Philadelphia, PA
Pascal Maisonobe, Ipsen, Boulogne-Billancourt, France
Stefan Wietek, Ipsen, Cambridge, MA

Document Type

Conference Proceeding

Publication Date

1-16-2021

Publication Title

Toxicon

Abstract

TOXINS 2021 Virtual Conference, January 16 - 17, 2021, Virtual

First Page

S28

Volume

190

Issue

(Suppl_1)

Comments

TOXINS 2021 Virtual Conference

Rights

© 2020 Published by Elsevier Ltd.

Recommended Citation

Gormley, Mark; Dabrowski, Edward; Tilton, Ann; Christian, Asare; Evans, Sarah Helen; Maisonobe, Pascal; and Wietek, Stefan, "Efficacy and safety of abobotulinumtoxinA in pediatric lower limb spasticity (PLLS): 2nd interim results from a Phase IV, prospective, observational, multicenter study" (2021). School of Medicine Faculty Publications. 1234.
https://digitalscholar.lsuhsc.edu/som_facpubs/1234
10.1016/j.toxicon.2020.11.398